Community-acquired thoracic empyema in young adults

Southern Medical Journal

Volumn 100, Issue 11, 2007, Pages 1075-1080

  Liang, Shinn Jye ^a   Chen, Wei ^a   Lin, Yu Chao ^a   Tu, Chih Yen ^a   Chen, Hung Jen ^a   Tsai, Yu Lin ^a   Shih, Chuen Ming ^a  

^a NONE

Author keywords

Community acquired; Thoracic empyema; Young adult

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; UROKINASE;

ADULT; ALCOHOLISM; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EMPYEMA; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE; THORACOSCOPY; THORAX DRAINAGE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALCOHOLISM; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; DRAINAGE; EMPYEMA, PLEURAL; FEMALE; HUMANS; MALE; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; STREPTOCOCCAL INFECTIONS; THORACIC SURGERY, VIDEO-ASSISTED; TREATMENT OUTCOME; VIRIDANS STREPTOCOCCI;

EID: 35948960333     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318158ba49     Document Type: Article

References (20)

1. Light RW, Girard WM, Jenkinson SGS, George RB., Parapneumonic effusions. Am J Med 1980;69:507-512.
2. Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993;148:813-817.
3. Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. Q J Med 1996;89:285-289.
4. Tu CY, Hsu WH, Hsia TC, et al. The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 2006;32:570-576.
5. Chen KY, Hsueh PR, Liaw YS, et al. A 10-year experience with bacteriology of acute thoracic empyema. Chest 2000;117:1685-1689.
6. Maskell NA, Davies CW, Jones E, Davies RJO. The characteristics of 300 patients participating in the MRC/BTS multicentre intra-pleural streptokinase vs. placebo triaL (ISRCTN-39138989). American Thoracic Society. Atlanta, GA; 2002.
7. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004;59:522-525.
8. Lindstrom ST, Kolbe J. Community acquired parapneumonic thoracic empyema: predictors of outcome. Respirology 1999;4:173-179.
9. Tsai TH, Jemg JS, Chen KY, et al. Community-acquired thoracic empyema in older people. J Am Geriatr Soc 2005;53:1203-1209.
10. Heffner JE, Brown LK, Barieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusion: a meta-analysis. Am J Respir Crit Care Med 1995;151:1700-1708.
11. Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
12. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003;58(Suppl 2):ii-18-ii-28.
13. Alfageme I, Munoz F, Pena N, Umbria S. Empyema of the thorax in adults: etiology, microbiologic findings, and management. Chest 1993;103:839-843.
14. Martella AT, Santos GH. Decortication for chronic postpneumonic empyema. J Am Coll Surg 1995;180:573-576.
15. Maskell NA, Davies RJ. Effusions from parapneumonic infection and empyema. In: Light, RW Lee YC, eds. Textbook of Pleural Diseases. London, Arnold Publishers, 2003, pp 310-328.
16. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997;10:1150-1156.
17. Wait MA, Sharma S, Hohn J, Dal NA. A randomized trial of empyema therapy. Chest 1997;111:1548-1551.
18. Petrkis IE, Kogerakis NE, Drositis IE, et al. Video-assisted thoracoscopic surgery for thoracic empyema: primarily, or after fibrinolytic therapy failure? Am JSurg 2004;187:471-474.
19. Athanassiadi K, Gerazounis M, Kalantzi N, Treatment of post-pneumonic empyema thoracic. Thorac Cardiovasc Sung 2003;51:338-341.
20. Mandal AK, Thadepalli H, Mandal AK, Chettipally U. Outcome of primary empyema thoracic: therapeutic and microbiologic aspects. Ann Thorac Sung 1998;66:1782-1786.